SOTERA HEALTH COMPANY Payments of Debt Issuance Costs
SOTERA HEALTH COMPANY (SHC) reported Payments of Debt Issuance Costs of $878.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-06
- SOTERA HEALTH COMPANY payments of debt issuance costs for the quarter ending 2026-06-30 was $878.00K, a 62.09% decline year-over-year.
- SOTERA HEALTH COMPANY payments of debt issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY payments of debt issuance costs for the quarter ending 2025-06-30 was $2.32M.
- SOTERA HEALTH COMPANY payments of debt issuance costs for the quarter ending 2025-03-31 was $10.00K, a 99.23% decline year-over-year.
- SOTERA HEALTH COMPANY payments of debt issuance costs for fiscal 2023 was $25.64M, a 82625.81% increase from fiscal 2022.
- SOTERA HEALTH COMPANY payments of debt issuance costs for fiscal 2022 was $31.00K, a 99.54% decline from fiscal 2021.
- SOTERA HEALTH COMPANY payments of debt issuance costs for fiscal 2021 was $6.79M, a 65.60% decline from fiscal 2020.
- SOTERA HEALTH COMPANY payments of debt issuance costs for fiscal 2020 was $19.75M, a 15.92% increase from fiscal 2019.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $878.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | |||
| 2025-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.33M 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-05 | |||
| 2024-03-31 | $1.29M 10-Q · filed 2025-05-01 | $1.29M derived: sum of 2 quarters · filed 2025-05-01 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $25.64M 10-K · filed 2024-02-27 | ||
| 2023-09-30 | $25.64M 10-Q · filed 2023-11-01 | |||
| 2023-03-31 | $24.46M 10-Q · filed 2024-05-02 | $24.46M derived: sum of 2 quarters · filed 2024-05-02 | $24.46M derived: sum of 3 quarters · filed 2024-05-02 | $24.46M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.00K derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $31.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $31.00K 10-Q · filed 2023-11-01 | $105.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $27.00K 10-Q · filed 2022-08-04 | $101.00K derived: sum of 3 quarters · filed 2024-02-27 | $3.16M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $31.00K 10-Q · filed 2023-05-03 | $105.00K derived: sum of 2 quarters · filed 2024-02-27 | $3.16M derived: sum of 3 quarters · filed 2024-02-27 | $3.39M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.13M derived: sum of 2 quarters · filed 2024-02-27 | $3.36M derived: sum of 3 quarters · filed 2024-02-27 | $6.79M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.28M derived: sum of 2 quarters · filed 2022-11-02 | $6.72M 10-Q · filed 2022-11-02 | $22.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.66M 10-Q · filed 2022-08-04 | $19.51M derived: sum of 3 quarters · filed 2023-02-28 | $23.27M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $3.44M 10-Q · filed 2022-05-05 | $19.28M derived: sum of 2 quarters · filed 2023-02-28 | $23.04M derived: sum of 3 quarters · filed 2023-02-28 | $22.97M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $19.60M derived: sum of 2 quarters · filed 2023-02-28 | $19.54M derived: sum of 3 quarters · filed 2023-02-28 | $19.75M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.69M derived: sum of 2 quarters · filed 2021-11-10 | $3.90M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $142.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $207.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $17.03M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |